Image

Fasciotomy and Predilation for Radial Artery Grafts in CABG

Fasciotomy and Predilation for Radial Artery Grafts in CABG

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to learn if a new way to prepare a radial artery graft during coronary artery bypass grafting (CABG) can improve outcomes for adults having this surgery. CABG is a heart surgery that uses a blood vessel to bypass blocked arteries in the heart. The radial artery is a blood vessel taken from the arm and used as a graft.

The new way combines two steps:

Fasciotomy: a small cut in the tissue around the graft to release pressure.

Predilation: gently filling the graft with a medicine solution to widen it and check for damage.

Researchers will compare this new way with the standard way of harvesting the radial artery.

The main questions it aims to answer are:

Does the new way lower the chance of death, heart attack, another procedure to restore blood flow through the graft, or graft failure within 1 year after surgery?

Does it improve blood flow and keep the radial artery graft open?

Is it safe?

Participants will:

Be adults scheduled to have CABG using a radial artery graft.

Be assigned by chance to one of two groups: the new way or the standard way.

Have CABG surgery.

Visit the clinic at 7 days, 30 days, 6 months, and 12 months after surgery.

Have a special heart scan (coronary computed tomography angiography, CCTA) at 7 days and 12 months to check the graft.

Allow researchers to collect medical information and record any health problems.

Researchers will compare the two groups to see if the new way works better than the standard way.

Eligibility

Inclusion Criteria:

  • Scheduled for coronary artery bypass grafting (CABG) and planned use of radial artery (RA) grafts

Exclusion Criteria:

  • Emergency CABG or redo CABG
  • Planned concomitant cardiac or non-cardiac surgery
  • Contraindications to coronary computed tomography angiography (CCTA), including pregnancy, uncontrolled severe iodine contrast allergy, or severe renal insufficiency (eGFR \< 30 mL/min/1.73 m²)
  • Any condition that, in the investigator's judgment, would preclude safe participation, completion of informed consent, or follow-up
  • Inability to provide written informed consent

Study details
    Coronary Artery Bypass
    Radial Artery Grafts

NCT07868692

Ruijin Hospital

31 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.